0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global crohn s disease drugs market research report 2019.Your search for "" gave back 1533064 results.
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Drugs In Development, 2021 Summary Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure...
Catalog:
GIR
January 2023
Price: USD 3,480.00
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021 Summary C-C Chemokine Receptor Type...
Catalog:
Global Markets Direct
September 2021
Price: USD 3,500.00
Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H2 2019 Summary Transient Receptor Potential Cation Channel...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Protein Phosphatase 2A - Pipeline Review, H1 2020 Summary Protein Phosphatase 2A (PP2A or EC 3.1.3.16) pipeline Target constitutes close to 7...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Matrix Metalloproteinase 9 - Pipeline Review, H2 2019 Summary Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2019 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications,...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha - Pipeline Review, H2 2019 Summary Granulocyte Macrophage Colony Stimulating...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Drugs in Development, 2021 Summary Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline...
Catalog:
Global Markets Direct
September 2021
Price: USD 3,500.00
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021 Summary According to the...
Catalog:
Global Markets Direct
November 2021
Price: USD 3,500.00
Macrophage Migration Inhibitory Factor - Pipeline Review, H2 2019 Summary Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
